Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Accept all cookies Reject all non-essential cookies Find out more

A critical analysis of recent data on zidovudine therapy: use in asymptomatic HIV infection and early HIV disease, dosing and resistance issues.

Peto TE.

More information Original publication

DOI

10.1097/00002030-199001001-00030

Type

Journal article

Publication Date

1990-01-01T00:00:00+00:00

Volume

4 Suppl 1

Pages

S187 - S191

Addresses

N, u, f, f, i, e, l, d, , D, e, p, a, r, t, m, e, n, t, , o, f, , C, l, i, n, i, c, a, l, , M, e, d, i, c, i, n, e, ,, , J, o, h, n, , R, a, d, c, l, i, f, f, e, , H, o, s, p, i, t, a, l, ,, , O, x, f, o, r, d, ,, , U, K, .

Keywords

Humans, HIV Infections, Zidovudine, Dose-Response Relationship, Drug, Drug Resistance, Clinical Trials as Topic